NCT07533942 2026-04-16
A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma
Jazz Pharmaceuticals
Phase 2 Not yet recruiting
Jazz Pharmaceuticals
Vanderbilt-Ingram Cancer Center
Weill Medical College of Cornell University
Exelixis
Hospices Civils de Lyon
University of California, San Francisco
University of Malaya
University Hospital, Montpellier
Centre Hospitalier St Anne